Clinical Trial Update: A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of GNC-077 in patients with non-small cell lung cancer and other solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• GNC-077

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Non-small Cell Lung Cancer, Solid Tumor | Phase 1 | Status: RECRUITING